Harvard Apparatus Regenerative Technology, Inc. 8-K/A

What Happened Harvard Apparatus Regenerative Technology, Inc. (HRGN) filed an amendment to a previously reported Form 8‑K (filed April 15, 2026) to correct which items of the form apply. The amendment, filed August 3, 2026, clarifies that the underlying transaction was the entry into a material definitive agreement — a Bridge Note dated April 13, 2026 — which creates a direct financial obligation to creditor Junli He. The company states no other changes were made to the original report.

Key Details

• Amendment date: August 3, 2026 (to a Form 8‑K originally filed April 15, 2026).
• Agreement: Bridge Note dated April 13, 2026, in favor of Junli He (filed as Exhibit 10.1 and incorporated by reference to the April 15, 2026 8‑K).
• Reporting correction: The transaction should have been reported under Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation), not under Item 1.02 (Termination).
• No other disclosures or updates to the original 8‑K were made by this amendment.

Why It Matters This amendment formally discloses that HRGN entered into short‑term financing (a bridge note) that creates a debt obligation; that can affect the company’s capital structure and liquidity. The filing is primarily an accounting/reporting correction to meet SEC disclosure rules — investors should review the April 15, 2026 8‑K and Exhibit 10.1 (the Bridge Note) for the note’s specific economic terms (principal, interest, maturity and any conversion features) to assess the material financial impact.